Daewoong Pharma (069620) — Strategic Asset Allocation Index
Daewoong Pharma (069620) has a Strategic Asset Allocation Index of 55.7% as of June 2023. Strategic assets (PP&E of ₩459.49 Billion plus long-term investments of ₩-) total ₩459.49 Billion, measured against net assets of ₩824.97 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Daewoong Pharma asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Daewoong Pharma Strategic Asset Allocation Index (2007–2022)
This chart shows how Daewoong Pharma's Strategic Asset Allocation Index has evolved across 14 annual periods from 2007 to 2022. As of June 2023, the index stands at 55.7%, representing strategic assets of ₩459.49 Billion against net assets of ₩824.97 Billion KRW. See Daewoong Pharma leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Daewoong Pharma (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Daewoong Pharma from 2007 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 069620 company net worth.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 59.5% | ₩440.89 Billion | ₩440.89 Billion | ₩- | ₩741.22 Billion | ▲ +3.1 pp |
| 2021 | 56.4% | ₩395.87 Billion | ₩395.87 Billion | ₩- | ₩702.41 Billion | ▼ -0.3 pp |
| 2020 | 56.6% | ₩393.69 Billion | ₩393.69 Billion | ₩- | ₩695.25 Billion | ▼ -10.0 pp |
| 2019 | 66.7% | ₩423.85 Billion | ₩391.71 Billion | ₩32.14 Billion | ₩635.92 Billion | ▼ -2.3 pp |
| 2018 | 69.0% | ₩419.25 Billion | ₩401.13 Billion | ₩18.12 Billion | ₩607.81 Billion | ▲ +5.0 pp |
| 2017 | 64.0% | ₩404.20 Billion | ₩396.16 Billion | ₩8.05 Billion | ₩631.54 Billion | ▲ +1.8 pp |
| 2016 | 62.2% | ₩375.75 Billion | ₩367.08 Billion | ₩8.67 Billion | ₩604.55 Billion | ▲ +16.3 pp |
| 2015 | 45.9% | ₩266.11 Billion | ₩255.84 Billion | ₩10.26 Billion | ₩580.24 Billion | ▲ +8.0 pp |
| 2014 | 37.8% | ₩172.36 Billion | ₩160.11 Billion | ₩12.25 Billion | ₩455.51 Billion | ▲ +3.7 pp |
| 2013 | 34.1% | ₩149.36 Billion | ₩132.62 Billion | ₩16.74 Billion | ₩437.96 Billion | ▲ +4.4 pp |
| 2012 | 29.7% | ₩114.86 Billion | ₩114.86 Billion | ₩- | ₩386.59 Billion | ▼ -0.1 pp |
| 2011 | 29.8% | ₩107.97 Billion | ₩107.97 Billion | ₩- | ₩362.42 Billion | ▼ -19.7 pp |
| 2008 | 49.5% | ₩138.06 Billion | ₩138.06 Billion | ₩- | ₩278.85 Billion | ▲ +6.7 pp |
| 2007 | 42.8% | ₩115.42 Billion | ₩115.42 Billion | ₩- | ₩269.57 Billion | — |